Intellia Therapeutics | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (51)

Latest Posts

About This Stock More About This Stock
Why Intellia Therapeutics, Inc. Outpaced The Stock Market
Article By: Zacks Investment Research
Sunday, May 5, 2024 11:37 AM EDT
Investors will be eagerly watching for the performance of Intellia Therapeutics, Inc. in its upcoming earnings disclosure.
In this article: NTLA
Read
What Is CRISPR And Why Should Your Portfolio Care?
Article By: Fred Fuld III
Sunday, June 25, 2023 3:01 PM EDT
CRISPR Therapeutics continues to be at the forefront of CRISPR-based therapeutics development. It's the first, and largest, but not the only player.
In this article: NVS, EDIT, NTLA, CRSP
Read
Top CRISPR Stocks
Article By: Fred Fuld III
Saturday, February 11, 2023 9:09 PM EDT
CRISPR is a narrow niche of the biotechnology industry, but it could become the fastest growing and most significant of all the biotech businesses.
In this article: EDIT, NTLA, CRSP Also: NVS
Read
When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader?
Article By: Rod Raynovich
Sunday, February 5, 2023 8:10 PM EDT
A few small cap biotechs lost momentum last week so now might be the time to take profits. But many of these stocks are favored because of their core technology and favored by funds; time to buy?
In this article: NTLA, IBB, PACB, XBI, SUPN, CRSP, ARKG, VCYT Also: CYRX, GERN, QDEL, HOLX, VRTX, EXAS, EVH, NVTA, TDOC
Read
Market Forecasts For 4th Quarter 2021 And Beyond
Article By: Herbert Blank
Wednesday, October 20, 2021 7:00 AM EDT
1-, 3-, 6- and 12-month forecasts for S&P 500, MidCap, Small Cap, Growth, Value and Nasdaq-100.
In this article: QQQ, IVV, IWD, IWF, IWM, MDY, AMC, SEDG, NTLA
Read

Latest Tweets for $NTLA

No tweets yet!

PARTNER HEADLINES

$NTLA

Market Forecasts For 4th Quarter 2021 And Beyond
Herbert Blank 10/20/2021 2:29:11 PM

I did not list in the Tickers covered portion 3 stocks mentioned in the article with purchase recommendations: AMC Entertainment ($AMC), Intella Theraputics ($NTLA) and SolarEdge Tech. ($SEDG).  Please excuse the oversight.  All the reports are available free of charge.

1 to 1 of 1 comments